Table 4.4 Reported cases of laboratory-confirmed, chronic (past or present) hepatitis C infection, by sex, race/ethnicity, age group, and case criteria — Enhanced Viral Hepatitis Surveillance Sites, 2010
Category | CO No. (%) | CT No. (%) | MN No. (%) | NM No. (%) | NY State No. (%) | NY City No. (%) | OR No. (%) | San Francisco No. (%) | Total No. (%) |
---|---|---|---|---|---|---|---|---|---|
Sex | |||||||||
Female | 1063 (34.4) | 1029 (33.4) | 664 (37.5) | 857 (29.1) | 2155 (32.8) | 3470 (34.6) | 1247 (36.5) | 537 (31.8) | 11022 (32.3) |
Male | 2030 (65.6) | 2053 (66.6) | 1092 (61.6) | 2086 (70.9) | 4410 (67.1) | 6510 (65.0) | 2157 (63.2) | 1125 (66.6) | 21463 (62.8) |
Unknown/Miss | 0 (0.0) | 0 (0.0) | 17 (1.0) | 1 (0.0) | 4 (0.1) | 41 (0.4) | 11 (0.3) | 28 (1.7) | 102 (0.3) |
Race/Ethnicity* | |||||||||
AI / AN | 26 (0.8) | 5 (0.2) | 98 (5.5) | 66 (2.2) | 29 (0.4) | 0 (0.0 ) | 53 (1.6) | 12 (0.7) | 289 (0.9) |
API | 25 (0.8) | 39 (1.3) | 47 (2.7) | 1 (0.0) | 79 (1.2) | 145 (1.5) | 15 (0.4) | 87 (5.2) | 438 (1.3) |
Black | 180 (5.8) | 365 (11.8) | 196 (11.1) | 11 (0.4) | 851 (13.0) | 1175 (11.7) | 76 (2.2) | 355 (21.0) | 3209 (9.4) |
White | 1089 (35.2) | 1274 (41.3) | 744 (42.0) | 278 (9.4) | 2641 (40.2) | 697 (7.0) | 1095 (32.1) | 537 (31.8) | 8355 (24.5) |
Hispanic | 381 (12.3) | 501 (16.3) | 52 (2.9) | 344 (11.7) | 653 (9.9) | 338 (3.4) | 57 (1.7) | 125 (7.4) | 2451 (7.2) |
Other | 13 (0.4) | 5 (0.2) | 23 (1.3) | 0 (0.0) | 45 (0.8) | 295 (2.9) | 24 (0.7) | 25 (1.5) | 437 (1.3) |
Unknown / Missing | 1379 (44.6) | 893 (29.0) | 613 (34.6) | 2244 (76.2) | 2264 (34.5) | 7371 (73.6) | 2095 (63.1) | 549 (32.5) | 17408 (50.9) |
Age group (yrs) | |||||||||
0-14 | 14 (0.5) | 5 (0.2) | 6 (0.3) | 6 (0.2) | 9 (0.1) | 71 (0.7) | 14 (0.4) | 4 (0.2) | 129 (0.4) |
15-24 | 111 (3.6) | 147 (4.8) | 108 (6.1) | 371 (12.6) | 336 (5.1) | 308 (3.1) | 84 (2.5) | 20 (1.2) | 1485 (4.3) |
25-39 | 590 (19.1) | 564 (18.3) | 265 (15.0) | 994 (33.8) | 1248 (19.0) | 1760 (17.6) | 492 (14.4) | 200 (11.8) | 6113 (17.9) |
40-54 | 1428 (46.2) | 1412 (45.8) | 787 (44.4) | 1078 (36.6) | 2650 (40.3) | 3714 (37.1) | 1609 (47.1) | 712 (42.1) | 13390 (39.2) |
55+ | 941 (30.4) | 954 (31.0) | 606 (34.2) | 495 (16.8) | 2323 (35.4) | 4168 (41.6) | 1209 (35.4) | 746 (44.1) | 11442 (33.5) |
Missing | 9 (0.3) | 0 (0.0) | 1 (0.1) | 0 (0.0) | 3 (0.1) | 0 (0.0) | 7 (0.2) | 8 (0.5) | 28 (0.1) |
Case criteria† | |||||||||
Anti-HCV and supplemental test | 222 (7.2) | 163 (5.3) | 240 (13.5) | U (U) | 689 (10.5) | 933 (9.3) | 171 ( 5.01) | 21 (1.2) | 2439 (7.1) |
RIBA | 351 (11.4) | 240 (7.8) | 403 (22.7) | U (U) | 936 (14.3) | 1449 (14.5) | 334 ( 9.78) | 54 (3.2) | 3767 (11.0) |
HCV RNA | 1594 (51.5) | 770 (25.0) | 1256 (70.8) | U (U) | 4392 (66.9) | 4753 (47.4) | 1746 (51.13) | 1150 (68.1) | 15661 (45.8) |
Genotype | 838 (27.1) | 128 (4.2) | 626 (35.3) | U (U) | 2291 (34.9) | 2649 (26.4) | 423 (12.4) | 554 (32.8) | 7509 (22.0) |
Anti-HCV and s/co ratio | 1701 (55.0) | 2377 (77.1) | 633 (35.7) | U (U) | 3806 (57.9) | 7993 (79.8) | 1424 (41.7) | 1002 (59.3) | 18936 (55.4) |
Total new reported cases | 3,093 | 3,082 | 1,773 | 2,944 | 6,569 | 10,021 | 3,415 | 1,690 | 32,587 |
Estimated 2010 population | 5,029,196 | 3,574,097 | 5,303,925 | 2,059,179 | 11,202,969 | 8,175,133 | 3,831,074 | 805,235 | 39,980,808 |
Rate per 100,000 population | 62.5 | 86.2 | 33.4 | 143.0 | 58.6 | 122.6 | 89.1 | 209.9 | 81.5 |
*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting.
- Page last reviewed: June 14, 2012
- Page last updated: August 26, 2013
- Content source: